LONG-TERM EFFICACY AND SAFETY OF PONATINIB IN HEAVILY PRETREATED LEUKEMIA PATIENTS: 4-YEAR RESULTS FROM THE PIVOTAL PHASE 2 PACE TRIALJ. E. Cortes,J. Pinilla-Ibarz,P. D. le Coutre,R. Paquette,C. Chuah,F. E. Nicolini,J. F. Apperley,H. J. Khoury,M. Talpaz,M. Baccarani,S. Lustgarten,F. G. Haluska,F. Guilhot,M. W. Deininger,A. Hochhaus,T. P. Hughes,N. P. Shah,H. M. KantarjianHAEMATOLOGICA（2016）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
